{"grounding": "A large body of evidence generated in the last two and a half years addresses the roles of T cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces multi-epitope CD4 and CD8 T cell responses with polyfunctionality. Early T cell responses have been associated with mild COVID-19 outcomes. In concert with animal model data, these results suggest that while antibody responses are key to prevent infection, T cell responses may also play valuable roles in reducing disease severity and controlling infection. T cell memory after vaccination is sustained for at least six months. While neutralizing antibody responses are impacted by SARS-CoV-2 variants, most CD4 and CD8 T cell responses are preserved. This review highlights the extensive progress made, and the data and knowledge gaps that remain, in our understanding of T cell responses to SARS-CoV-2 and COVID-19 vaccines.", "generated_text": "This study investigates the T cell responses to SARS-CoV-2, a critical component of the immune system's defense against COVID-19. Our analysis reveals that T cell responses to the virus are highly variable, with distinct patterns of recognition and activation in response to different variants. Notably, T cell epitopes that are targeted by neutralizing antibodies are also recognized by T cells, suggesting a coordinated immune response. Furthermore, our findings suggest that T cell responses to SARS-CoV-2 are influenced by disease severity, with individuals experiencing more severe disease exhibiting altered T cell profiles. The results also highlight the importance of vaccination in modulating T cell responses, with vaccinated individuals displaying enhanced T cell activation and proliferation. Overall, this study provides new insights into the complex T cell responses to SARS-CoV-2 and has implications for the development of effective COVID-19 vaccines and therapies.", "label": 1}